Oryzon

Nice & Green, the Swiss investment firm, announces today a … Nice & Green Renews Commitment to Oryzon Genomics with Up to EUR 45 million in New Funding

Nice & Green, the Swiss investment firm, provides financing of … Nice & Green provides funding of €20 million to Oryzon for executing clinical trials in oncology and CNS